Gao P - Search Results

1

Selective Inhibitors of G2019S-LRRK2 Kinase Activity.

Garofalo AW, Bright J, De Lombaert S, Toda AMA, Zobel K, Andreotti D, Beato C, Bernardi S, Budassi F, Caberlotto L, Gao P, Griffante C, Liu X, Mengatto L, Migliore M, Sabbatini FM, Sava A, Serra E, Vincetti P, Zhang M, Carlisle HJ. Garofalo AW, et al. Among authors: gao p. J Med Chem. 2020 Dec 10;63(23):14821-14839. doi: 10.1021/acs.jmedchem.0c01243. Epub 2020 Nov 16. J Med Chem. 2020. PMID: 33197196

2

Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies.

Sun C, Fang L, Zhang X, Gao P, Gou S. Sun C, et al. Among authors: gao p. Bioorg Med Chem. 2019 May 15;27(10):1932-1941. doi: 10.1016/j.bmc.2019.04.018. Epub 2019 Apr 10. Bioorg Med Chem. 2019. PMID: 30987781

3

Novel anilinopyrimidine derivatives as potential EGFR^T790M/C797S Inhibitors: Design, Synthesis, biological activity study.

Guo Y, Gao B, Gao P, Fang L, Gou S. Guo Y, et al. Among authors: gao p, gao b. Bioorg Med Chem. 2022 Sep 15;70:116907. doi: 10.1016/j.bmc.2022.116907. Epub 2022 Jul 5. Bioorg Med Chem. 2022. PMID: 35810715

4

Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activity.

Garofalo AW, Schwarz J, Zobel K, Beato C, Bernardi S, Budassi F, Caberlotto L, Gao P, Griffante C, Liu X, Migliore M, Qiao F, Sabbatini FM, Sava A, Zhang M, Carlisle HJ. Garofalo AW, et al. Among authors: gao p. Bioorg Med Chem Lett. 2023 Oct 15;95:129487. doi: 10.1016/j.bmcl.2023.129487. Epub 2023 Sep 19. Bioorg Med Chem Lett. 2023. PMID: 37734423

5

Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers.

Wen T, Wang J, Lu R, Tan S, Li P, Yao X, Liu H, Yi Z, Li L, Liu S, Gao P, Qian H, Xie G, Ma F. Wen T, et al. Among authors: gao p. Eur J Med Chem. 2023 Mar 15;250:115199. doi: 10.1016/j.ejmech.2023.115199. Epub 2023 Feb 17. Eur J Med Chem. 2023. PMID: 36827953 Free article.

6

Design, synthesis and biological evaluation of phosphoroxy quinazoline derivatives as potential EGFR^T790M/C797S inhibitors.

Guo Y, Gao B, Gao P, Wang Y, Gou S. Guo Y, et al. Among authors: gao p, gao b. Bioorg Med Chem. 2023 Jul 15;90:117338. doi: 10.1016/j.bmc.2023.117338. Epub 2023 May 19. Bioorg Med Chem. 2023. PMID: 37269687

7

Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.

Neumeyer JL, Bidlack JM, Zong R, Bakthavachalam V, Gao P, Cohen DJ, Negus SS, Mello NK. Neumeyer JL, et al. Among authors: gao p. J Med Chem. 2000 Jan 13;43(1):114-22. doi: 10.1021/jm9903343. J Med Chem. 2000. PMID: 10633042

8

Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.

Gao P, Larson DL, Portoghese PS. Gao P, et al. J Med Chem. 1998 Jul 30;41(16):3091-8. doi: 10.1021/jm9802214. J Med Chem. 1998. PMID: 9685249

9

Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration.

Gao P, Li X, He Z, Zhang H, Zhang Z, Liu Z. Gao P, et al. Int Med Case Rep J. 2024 Apr 18;17:359-365. doi: 10.2147/IMCRJ.S449525. eCollection 2024. Int Med Case Rep J. 2024. PMID: 38651079 Free PMC article.

10

Abundance of Modifications in Mature miRNAs Revealed by LC-MS/MS Method Coupled with a Two-Step Hybridization Purification Strategy.

Lü C, Xu H, Gao P, Huang A, Qu M, He W, Wu H, Chen J, Xu B, Guo L, Xie J. Lü C, et al. Among authors: gao p. Anal Chem. 2024 Apr 22. doi: 10.1021/acs.analchem.4c01326. Online ahead of print. Anal Chem. 2024. PMID: 38648202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,632 results

Search Page